Abstract
The pharmacokinetics of cefamandole, a new cephalosporin, were investigated in 23 patients with urinary tract infections and normal or varying degrees of impairment of renal function. A daily dose of 1.5 to 3.0 g administered intramuscularly was tolerated well and resulted in very high urine concentrations. The pharmacokinetics of the antibiotic were compared with isotopically labeled [131I]hippurate and [125I]iothalamate, which were used for determination of effective renal plasma flow and glomerular filtration rate, respectively. It was shown that cefamandole was excreted by glomerular filtration as well as by active tubular secretion. Probenecid inhibited the tubular secretion of cefamandole. The serum half-life of cefamandole in patients with normal renal function was approximately 1.5 h and increased in patients along with increasing impairment of renal function. Our studies indicate that a dosage regimen of 1 g of cefamandole every 8 h in patients with normal renal function results in urine concentrations sufficiently high for treatment of most common urinary tract infections. In patients with impaired renal function, the dosage interval should be increased or the dosage lowered according to the serum creatinine values.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Elwood C. M., Sigman E. M. The measurement of glomerular filtration rate and effective renal plasma flow in man by iothalamate 125-I and iodopyracet 131-I. Circulation. 1967 Sep;36(3):441–448. doi: 10.1161/01.cir.36.3.441. [DOI] [PubMed] [Google Scholar]
- Eykyn S., Jenkins C., King A., Phillips I. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973 Jun;3(6):657–661. doi: 10.1128/aac.3.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fong I. W., Ralph E. D., Engelking E. R., Kirby W. M. Clinical pharmacology of cefamandole as compared with cephalothin. Antimicrob Agents Chemother. 1976 Jan;9(1):65–69. doi: 10.1128/aac.9.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KUNIN C. M. Serum binding, distribution and excretion of four penicillin analogues following intravenous injection in man. Proc Soc Exp Biol Med. 1961 Jun;107:337–341. doi: 10.3181/00379727-107-26618. [DOI] [PubMed] [Google Scholar]
- Meyers B. R., Ribner B., Yancovitz S., Hirschman S. Z. Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother. 1976 Jan;9(1):140–144. doi: 10.1128/aac.9.1.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother. 1974 Aug;6(2):177–182. doi: 10.1128/aac.6.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SAPIRSTEIN L. A., HERROLD M. R., JANAKIS M., OGDEN E. Validity of values for glomerular filtration rate and extracellular fluid obtained from plasma concentration-time decay curves after single injections of mannitol in the dog. Am J Physiol. 1952 Nov;171(2):487–491. doi: 10.1152/ajplegacy.1952.171.2.487. [DOI] [PubMed] [Google Scholar]
- WAGONER R. D., TAUXE W. N., MAHER F. T., HUNT J. C. MEASUREMENT OF EFFECTIVE RENAL PLASMA FLOW WITH SODIUM IODOHIPPURATE I-131. JAMA. 1964 Mar 14;187:811–813. doi: 10.1001/jama.1964.03060240019004. [DOI] [PubMed] [Google Scholar]
- Wick W. E., Preston D. A. Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics. Antimicrob Agents Chemother. 1972 Mar;1(3):221–234. doi: 10.1128/aac.1.3.221. [DOI] [PMC free article] [PubMed] [Google Scholar]